after tirzepatide SHOCKING Month 2 Results What to Expect on Tirzepatide:

TC is the most common endocrine cancer, which has raised concern due to its rapidly increasing prevalence

Educational Disclaimer: This content is for informational purposes only and is not intended to provide medical advice, diagnosis, or treatment recommendations

Andrew Huberman on Retatrutide: What He Said and What the Data Shows "The Peptide That Changes Everything." Huberman a professor of neurobiology at Stanford School of Medicine and host of the Huberman Lab podcast described retatrutide as the most significant peptide in development, called it a potential "trillion dollar drug," and discussed its implications for weight loss, bodybuilding, alcohol consumption, and regulation

However, the MC4R agonist setmelanotide was recently FDA-approved, representing a significant advancement in the treatment of rare genetic forms of obesity [64, 104]